Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial

57

Citations

29

References

2016

Year

Tassanee Sriprayoon, Chulabhorn Mahidol, Teerapat Ungtrakul, Pattra Chun‐on, Kamonwan Soonklang, Wanvisa Pongpun, Charlie Laohapand, Jiraporn Dechma, Charinthip Pothijaroen, Chirayu Auewarakul,

Hepatology Research

Abstract

Both ETV and TDF showed potent antiviral activity against hepatitis B. Either ETV or TDF can be recommended as a treatment of choice for patients with chronic hepatitis B. Both drugs were safe and well tolerated.

References

	Year	Citations

Page 1